Cardiocontin vs. Nitrocontin: Delhi HC Warns of Life-Threatening Confusion Over Pharma Trademarks Farhat Nasim11 Dec 2024 5:12 PM ISTNew Delhi: The Delhi High Court has raised concerns over the potential risk of consumer confusion between the trademarks of Modi-Mundipharma Pvt....
NPPA Mandates Transparency in Angioplasty Billing with Separate Costs for Non-Stent Components: MoS Anupriya Patel Farhat Nasim10 Dec 2024 3:04 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) mandates for hospitals performing angioplasty to itemize billing costs for non-stent...
Revise protocol for conducting Phase I CT in India: CDSCO Panel Tells Biological E on Typhoid and Paratyphoid A Bivalent Vaccine Dr. Divya Colin9 Dec 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I clinical trial report of Typhoid and Paratyphoid A Bivalent Vaccine conducted in Europe, the Subject Expert...
Conduct phase III clinical study on resistant hypertension: CDSCO Panel tells Sun Pharmaceutical Industries on Esaxerenone Dr. Divya Colin8 Dec 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Sun Pharmaceutical Industries to manufacture and market the drug Esaxerenone tablets...
Pfizer Gets CDSCO Panel Nod To Import 20 Valent Pneumococcal Conjugate Vaccine Dr. Divya Colin7 Dec 2024 5:45 PM ISTNew Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Drug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole Susmita Roy6 Dec 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed adverse...
Deaths of Pregnant Women After Administration of Contaminated Ringer's Lactate Solution: CDSCO Under Scanner Farhat Nasim5 Dec 2024 5:57 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) is under scrutiny as the Karnataka government seeks clarification regarding reports...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review Farhat Nasim3 Dec 2024 2:57 PM ISTNew Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg...
Delhi HC Upholds AstraZeneca's Tagrisso Patent, Imposes Rs 7L Fine on 'Habitual Infringer' for Knockoff Production Farhat Nasim2 Dec 2024 4:48 PM ISTNew Delhi: In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical Works Ltd....
27 Formulations Declared Not of Standard Quality, 7 Misbranded: CDSCO Alert Based on State Data Farhat Nasim1 Dec 2024 12:00 PM ISTNew Delhi: The State Drugs Control Laboratories, under the Central Drugs Standard Control Organisation (CDSCO), have issued a detailed alert for...
CDSCO flags PAN-D, TAXIM-O 200, Rosuvas 10 samples as spurious in October 2024 alert Farhat Nasim30 Nov 2024 2:49 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has declared three drugs, Pantoprazole Gastro-resistant and Domeperiodone Prolong...
